Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Oncol. May 24, 2022; 13(5): 352-365
Published online May 24, 2022. doi: 10.5306/wjco.v13.i5.352
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Overall Kaplan-Meier survival curve. Median survival for all patients is 34 (95%CI: 27-41) mo.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Kaplan-Meier survival curve by age groups. Median survival for patients ≤ 19-years-old is 85 (95%CI: 37-137) mo, patients between 20 and 59-years-old are 29 (18-41) mo, and patients ≥ 60-years-old is 12 (95%CI: 7-31) mo (P < 0.001).
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Kaplan-Meier survival curve by race (all race). Median survival for White 39 (95%CI: 29-63) mo, Black 26 (95%CI: 5-92) mo, Asian and Pacific Islander is 28 (95%CI: 6-39) mo, and Hispanic 31 (95%CI: 11-54) mo (P = 0.28).
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Kaplan-Meier survival curve by race (White vs non-White). Median survival for White 39 (95%CI: 29-63) mo, and Non-White is 29 (95%CI: 15-38) mo (P = 0.11).
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Kaplan-Meier survival curve by surgery types. Median survival for a wedge or segmental resection was 112 (95%CI: 78-NA) mo, lobectomy was 92 (95%CI: 57-NA) mo, extended lobectomy was 54 (95%CI: 23-NA) mo, none had 10 (95%CI: 6-13) mo, and the transplant was 63 (95%CI: 20-NA) mo (P < 0.001).
Figure 6
Open in New Tab Full Size Figure Download Figure
Figure 6 Kaplan-Meier survival curve by surgical status and metastasis status. Median survival for NM+/no surgery was 9 (95%CI: 4-14) mo, NM+/surgery was 54 (95%CI: 34-85) mo, NM-/no surgery was 11 (95%CI: 6-17) mo, and NM-/surgery was 142 (95%CI: 92-NA) mo (P < 0.001).